Thomas J. Dengler

7.3k total citations
109 papers, 4.2k citations indexed

About

Thomas J. Dengler is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Thomas J. Dengler has authored 109 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 29 papers in Surgery and 27 papers in Immunology. Recurrent topics in Thomas J. Dengler's work include Transplantation: Methods and Outcomes (23 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers) and Atherosclerosis and Cardiovascular Diseases (13 papers). Thomas J. Dengler is often cited by papers focused on Transplantation: Methods and Outcomes (23 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers) and Atherosclerosis and Cardiovascular Diseases (13 papers). Thomas J. Dengler collaborates with scholars based in Germany, United States and Hungary. Thomas J. Dengler's co-authors include Hugo A. Katus, Arnt V. Kristen, Falk‐Udo Sack, Philipp A. Schnabel, Jordan S. Pober, Christian Erbel, George D. Yancopoulos, Peter C. Maisonpierre, Guillermo García‐Cardeña and Andreas Papapetropoulos and has published in prestigious journals such as Circulation, Blood and The Journal of Immunology.

In The Last Decade

Thomas J. Dengler

108 papers receiving 4.2k citations

Peers

Countries citing papers authored by Thomas J. Dengler

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Dengler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Dengler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Dengler more than expected).

Fields of papers citing papers by Thomas J. Dengler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Dengler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Dengler. The network helps show where Thomas J. Dengler may publish in the future.

Co-authorship network of co-authors of Thomas J. Dengler

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Dengler. A scholar is included among the top collaborators of Thomas J. Dengler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Dengler. Thomas J. Dengler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 13387: Prognostic Value of a Novel Circulating Serum Galectin-3 Binding Protein for the Development of a Transplant Vasculopathy After Heart Transplantation 2011 ·Circulation ·Susanne Wangler, Thomas J. Dengler, Andreas Doesch, Hugo A. Katus, Christian Erbel	1
2	Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability 2010 ·Basic Research in Cardiology ·Christian Erbel, Thomas J. Dengler, Susanne Wangler, Felix Lasitschka, Florian Bea, (unknown), Maani Hakimi, Dittmar Böckler, Hugo A. Katus, Christian A. Gleissner	150
3	Return to Work After Heart Transplantation: Discrepancy With Subjective Work Ability 2009 ·Transplantation ·Arnt V. Kristen, (unknown), Achim Koch, Andreas Dösch, Christian Erbel, Sultan Celik, Matthias Karck, Falk‐Udo Sack, Hugo A. Katus, Thomas J. Dengler	18
4	Staged Heart Transplantation and Chemotherapy as a Treatment Option in Patients with Severe Cardiac Light-Chain Amyloidosis 2009 ·European Journal of Heart Failure ·Arnt V. Kristen, Falk‐Udo Sack, Stefan Schönland, Ute Hegenbart, Burkhard Helmke, Achim Koch, Philipp A. Schnabel, Christoph Röcken, Stefan E. Hardt, Andrew Remppis, Hartmut Goldschmidt, Matthias Karck, Anthony D. Ho, Hugo A. Katus, Thomas J. Dengler	37
5	Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice 2009 ·The Journal of Immunology ·Christian Erbel, Lili Chen, Florian Bea, Susanne Wangler, Sultan Celik, Felix Lasitschka, Ying Wang, Dittmar Böckler, Hugo A. Katus, Thomas J. Dengler	284
6	Beneficial Effect of Omega-3 Fatty Acids on Sirolimus- or Everolimus-Induced Hypertriglyceridemia in Heart Transplant Recipients 2008 ·Transplantation ·Sultan Celik, Andreas Doesch, Christian Erbel, Erwin Blessing, (unknown), Achim Koch, Hugo A. Katus, Thomas J. Dengler	33
7	Non-Invasive Predictors of Survival in Cardiac Amyloidosis 2007 ·European Journal of Heart Failure ·Arnt V. Kristen, Jolanta B. Perz, Stefan Schönland, Ute Hegenbart, Philipp A. Schnabel, (unknown), Hartmut Goldschmidt, Hugo A. Katus, Thomas J. Dengler	99
8	Incidence of CMV infections within the first 6 months after cardiac transplantation: concentration-controlled everolimus vs MMF 2007 ·Transplant International ·Mario Viganò, Alain Poncelet, Carlo Magelli, P. Boissonnat, I Gandjbakhch, Gino Gerosa, Thomas J. Dengler, Johan Vanhaecke, Kamal Abeywickrama, (unknown)	1
9	Intravenous Delivery of Autologous Mesenchymal Stem Cells Limits Infarct Size and Improves Left Ventricular Function in The Infarcted Porcine Heart 2007 ·Stem Cells and Development ·U. Krause, (unknown), Anja Seckinger, David Wolf, (unknown), Florian Bea, Thomas J. Dengler, Stefan Hardt, Anthony D. Ho, Hugo A. Katus, Helmut F. Kuecherer, Alexander Hansen	61
10	IL‐10 inhibits endothelium‐dependent T cell costimulation by up‐regulation of ILT3/4 in human vascular endothelial cells 2006 ·European Journal of Immunology ·Christian A. Gleissner, Arne Zastrow, Roland Klingenberg, Martin S. Kluger, Mathias H. Konstandin, Sultan Celik, (unknown), (unknown), Thomas Giese, Hugo A. Katus, Thomas J. Dengler	35
11	A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A—Containing and cyclosporin A—Free immunosuppressive regimens 2006 ·Clinical Therapeutics ·Andreas Dösch, Philipp Ehlermann, Achim Koch, Andrew Remppis, Hugo A. Katus, Thomas J. Dengler	19
12	Pharmacodynamic Monitoring of Cyclosporine A in Renal Allograft Recipients Shows a Quantitative Relationship Between Immunosuppression and the Occurrence of Recurrent Infections and Malignancies 2006 ·Transplantation ·Claudia Sommerer, Mathias H. Konstandin, Thomas J. Dengler, Jan Schmidt, Stefan Meuer, Martin Zeier, Thomas Giese	70
13	Risk Stratification in Cardiac Amyloidosis: Novel Approaches 2005 ·Transplantation ·Arnt V. Kristen, F. Joachim Meyer, Jolanta B. Perz, Stefan Schönland, Michael Hundemer, Ute Hegenbart, (unknown), Philipp A. Schnabel, Falk‐Udo Sack, Hartmut Goldschmidt, Hugo A. Katus, Thomas J. Dengler	19
14	Stem Cell Therapy for the Infarcted Heart ("Cellular Cardiomyoplasty") 2002 ·Herz ·Thomas J. Dengler, Hugo A. Katus	23
15	Human Vascular Endothelial Cells Stimulate a Lower Frequency of Alloreactive CD8+ Pre-CTL and Induce Less Clonal Expansion than Matching B Lymphoblastoid Cells: Development of a Novel Limiting Dilution Analysis Method Based on CFSE Labeling of Lymphocytes 2001 ·The Journal of Immunology ·Thomas J. Dengler, David R. Johnson, Jordan S. Pober	29
16	Human Vascular Endothelial Cells Stimulate Memory But Not Naive CD8+ T Cells to Differentiate into CTL Retaining an Early Activation Phenotype 2000 ·The Journal of Immunology ·Thomas J. Dengler, Jordan S. Pober	77
17	Cytoprotection of Human Umbilical Vein Endothelial Cells Against Apoptosis and CTL-Mediated Lysis Provided by Caspase-Resistant Bcl-2 Without Alterations in Growth or Activation Responses 2000 ·The Journal of Immunology ·Zheng Lian, Thomas J. Dengler, Martin S. Kluger, Lisa A. Madge, Jeffrey S. Schechner, Stephen E. Maher, Jordan S. Pober, Alfred L.M. Bothwell	67
18	Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody production 1998 ·European Journal of Immunology ·Bernd Sido, Thomas J. Dengler, Gerd Otto, Rainer Zimmermann, Petra Müller, Stefan Meuer	17
19	Biological Response Modifiers Render Tumor Cells Susceptible to Autologous Effector Mechanisms by Influencing Adhesion Receptors 1993 ·Leukemia & lymphoma ·Carl Albrecht Schirren, (unknown), Jörg Hoffmann, Stefan Henning, Liang Qiao, Frank Autschbach, Thomas J. Dengler, Hartmut Döhner, Stefan Meuer	12
20	Structure of the capsular polysaccharide (K19 antigen) from uropathogenic Escherichia coli O25:K19:H12 1988 ·Carbohydrate Research ·Barbara Jann, (unknown), Thomas J. Dengler, Klaus Jann	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact